Barth P - Search Results

1

Prechemotherapy Education: Reducing Patient Anxiety Through Nurse-Led Teaching Sessions .

Apor E, Connell NT, Faricy-Anderson K, Barth P, Youssef R, Fenton M, Sikov WM, Thomas A, Rosati K, Schumacher A, Lombardo A, Korber S, Khurshid H, Safran H, Mega A. Apor E, et al. Among authors: barth p. Clin J Oncol Nurs. 2018 Feb 1;22(1):76-82. doi: 10.1188/18.CJON.76-82. Clin J Oncol Nurs. 2018. PMID: 29350695

2

Tolerability of ADXS11-001 Lm-LLO Listeria-Based Immunotherapy With Mitomycin, Fluorouracil, and Radiation for Anal Cancer.

Safran H, Leonard KL, Perez K, Vrees M, Klipfel A, Schechter S, Oldenburg N, Roth L, Shah N, Rosati K, Rajdev L, Mantripragada K, Sheng IY, Barth P, DiPetrillo TA. Safran H, et al. Among authors: barth p. Int J Radiat Oncol Biol Phys. 2018 Apr 1;100(5):1175-1178. doi: 10.1016/j.ijrobp.2018.01.004. Epub 2018 Jan 31. Int J Radiat Oncol Biol Phys. 2018. PMID: 29722659

3

Second primary malignancy among older adults with multiple myeloma receiving first-line lenalidomide-based therapy: A population-based analysis.

Giri S, Barth P, Costa LJ, Olszewski AJ. Giri S, et al. Among authors: barth p. J Geriatr Oncol. 2021 Mar;12(2):256-261. doi: 10.1016/j.jgo.2020.07.007. Epub 2020 Jul 17. J Geriatr Oncol. 2021. PMID: 32684352

4

The next generation of therapy for multiple myeloma: a review of ongoing clinical trials utilizing ClinicalTrials.gov.

Barth P, Vale C, Chambers AB, Reagan JL. Barth P, et al. Future Oncol. 2018 Aug;14(19):1965-1976. doi: 10.2217/fon-2017-0722. Epub 2018 Jul 18. Future Oncol. 2018. PMID: 30019947

5

Outcomes of lenalidomide- or bortezomib-based regimens in older patients with plasma cell myeloma.

Barth P, Giri S, Reagan JL, Olszewski AJ. Barth P, et al. Am J Hematol. 2021 Jan;96(1):14-22. doi: 10.1002/ajh.25996. Epub 2020 Oct 3. Am J Hematol. 2021. PMID: 32918301 Free article.

6

Prognostic significance of upfront radiation therapy in patients with multiple myeloma.

Orcutt X, Barth P, Olszewski AJ. Orcutt X, et al. Among authors: barth p. Am J Hematol. 2019 Jul;94(7):E190-E194. doi: 10.1002/ajh.25492. Epub 2019 May 1. Am J Hematol. 2019. PMID: 31006894 Free article. No abstract available.

7

Use of bone-modifying agents and clinical outcomes in older adults with multiple myeloma.

Olszewski AJ, Barth PM, Reagan JL. Olszewski AJ, et al. Cancer Med. 2019 Nov;8(16):6945-6954. doi: 10.1002/cam4.2591. Epub 2019 Sep 30. Cancer Med. 2019. PMID: 31566898 Free PMC article.

8

Outcomes of secondary solid tumor malignancies among patients with myeloma: A population-based study.

Barth P, Castillo JJ, Olszewski AJ. Barth P, et al. Cancer. 2019 Feb 15;125(4):550-558. doi: 10.1002/cncr.31853. Epub 2018 Nov 19. Cancer. 2019. PMID: 30452087 Free article.

9

Seroconversion and outcomes after initial and booster COVID-19 vaccination in adults with hematologic malignancies.

Ollila TA, Masel RH, Reagan JL, Lu S, Rogers RD, Paiva KJ, Taher R, Burguera-Couce E, Zayac AS, Yakirevich I, Niroula R, Barth P, Olszewski AJ. Ollila TA, et al. Among authors: barth p. Cancer. 2022 Sep 15;128(18):3319-3329. doi: 10.1002/cncr.34354. Epub 2022 Jul 11. Cancer. 2022. PMID: 35811461 Free PMC article.

10

Risk Stratification of Precursors to Multiple Myeloma in 2020.

Chudasama R, Barth P. Chudasama R, et al. Among authors: barth p. R I Med J (2013). 2020 Apr 1;103(3):46-47. R I Med J (2013). 2020. PMID: 32236162 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

685 results

Search Page

Filters